Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jan 9, 2023
Date Accepted: Jan 31, 2023

The final, peer-reviewed published version of this preprint can be found here:

Criteria for Advanced Prosthetic Foot Prescription: Rationale, Design, and Protocol for a Multisite, Randomized Controlled Trial

Maikos JT, Hendershot BD, Pruziner AL, Hyre MJ, Chomack JM, Phillips SL, Heckman JT, Sidiropoulos AN, Dearth CL, Nelson LM

Criteria for Advanced Prosthetic Foot Prescription: Rationale, Design, and Protocol for a Multisite, Randomized Controlled Trial

JMIR Res Protoc 2023;12:e45612

DOI: 10.2196/45612

PMID: 37014672

PMCID: 10131701

Criteria for Advanced Prosthetic Foot Prescription: Rationale, Design, and Protocol for a Multi-Site, Randomized Clinical Trial

  • Jason T. Maikos; 
  • Brad D. Hendershot; 
  • Alison L. Pruziner; 
  • Michael J. Hyre; 
  • John M. Chomack; 
  • Samuel L. Phillips; 
  • Jeffrey T. Heckman; 
  • Alexis N. Sidiropoulos; 
  • Christopher L. Dearth; 
  • Leif M. Nelson

ABSTRACT

Background:

Prescription of prosthetic ankle-foot devices is often based on the professional judgment of the amputation care team or limited evidentiary research. Current prosthetic research efforts have focused on the design and development of prosthetic devices rather than understanding which devices are most appropriate to prescribe. This investigation will evaluate biomechanical, functional, and subjective outcome measures to help determine optimal prescription parameters of prosthetic ankle-foot devices.

Objective:

To develop evidence-based guidelines for limb loss care teams for the appropriate prescription of commercially available prosthetic foot-ankle devices in order to improve function and satisfaction.

Methods:

This investigation will be a multi-site, randomized, cross-over clinical trial targeting enrollment of 100 participants. Participants utilize three different types of prosthetic devices (energy storing and returning, articulating, and powered) in random order. Participants will be fit and trained with each device and then separately utilize each device for a one-week acclimation period. Following each one-week acclimation, participants will be evaluated with several functional measures and subjective surveys. A random subset of participants (n=30) will also undergo full-body gait analysis, following each one-week acclimation period, to collect biomechanical data during level-ground and incline/decline walking. After all individual device evaluations, participants will be given all three prostheses concurrently for four weeks of home and community use to capture user preference. Activity monitoring and a guided interview will be used to determine overall user preference.

Results:

The study was funded in August of 2017 with data collection beginning in 2018. Data collection is expected to conclude prior to July 2023. Initial dissemination of results is expected in the winter of 2023.

Conclusions:

By identifying biomechanical, functional, and subjective outcomes that are sensitive to differences in prosthetic ankle-foot devices, a benchmark of evidence can be developed to guide effective prosthetic prescription. Clinical Trial: ClinicalTrials.gov Identifier: NCT03505983


 Citation

Please cite as:

Maikos JT, Hendershot BD, Pruziner AL, Hyre MJ, Chomack JM, Phillips SL, Heckman JT, Sidiropoulos AN, Dearth CL, Nelson LM

Criteria for Advanced Prosthetic Foot Prescription: Rationale, Design, and Protocol for a Multisite, Randomized Controlled Trial

JMIR Res Protoc 2023;12:e45612

DOI: 10.2196/45612

PMID: 37014672

PMCID: 10131701

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.